RT Journal Article
SR Electronic
T1 1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINE<sup>TM</sup> molecule that releases fully potent IL-2 in the tumor microenvironment
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1165
OP A1165
DO 10.1136/jitc-2023-SITC2023.1058
VO 11
IS Suppl 1
A1 Nirschl, Christopher J
A1 Brodkin, Heather R
A1 Hicklin, Daniel J
A1 Ismail, Nesreen
A1 Lewis, Yuka
A1 Seidel-Dugan, Cynthia
A1 Steuert, Zoe
A1 Sullivan, Jenna M
A1 Winston, William M
A1 Salmeron, Andres
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1165.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.